Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Changes to Pacira Pharmaceuticals' board

This article was originally published in Scrip

Executive Summary

Pacira Pharmaceuticals, a US-based speciality pharma company, has appointed Laura Brege and Paul Hastings to its board. Dr Carl Gordon is stepping down from the board, bringing the total number of board members to eight. Ms Brege serves as executive vice-president of corporate affairs for Onyx Pharmaceuticals, while Mr Hastings is president and CEO of OncoMed Pharmaceuticals.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC013181

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel